Interestingly, CD4+ T cells from RRMS expressed significant higher baseline levels of Glut1 compared to HD subjects and CD28 stimulation induced a higher Glut1 up-regulation in RRMS patients (Figure S3c). The gene discussed is SLC2A1; the disease is relapsing-remitting multiple sclerosis.